Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROMOSOZUMAB-AQQG Cause Bone density abnormal? 454 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 454 reports of Bone density abnormal have been filed in association with ROMOSOZUMAB-AQQG. This represents 4.0% of all adverse event reports for ROMOSOZUMAB-AQQG.

454
Reports of Bone density abnormal with ROMOSOZUMAB-AQQG
4.0%
of all ROMOSOZUMAB-AQQG reports
0
Deaths
1
Hospitalizations

How Dangerous Is Bone density abnormal From ROMOSOZUMAB-AQQG?

Of the 454 reports, 1 (0.2%) required hospitalization.

Is Bone density abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 454 reports have been filed with the FAERS database.

What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?

Fall (646) Fracture (612) Arthralgia (517) Injection site pain (490) Off label use (419) Hospitalisation (381) Headache (360) Product storage error (348) Death (263) Spinal fracture (256)

What Other Drugs Cause Bone density abnormal?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,039) DENOSUMAB (643) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (580) TENOFOVIR DISOPROXIL (310) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (276) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (199) ADALIMUMAB (174) METHOTREXATE (155) TERIPARATIDE (146) ETANERCEPT (145)

Which ROMOSOZUMAB-AQQG Alternatives Have Lower Bone density abnormal Risk?

ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT ROMOSOZUMAB-AQQG vs ROPINIROLE ROMOSOZUMAB-AQQG vs ROPIVACAINE ROMOSOZUMAB-AQQG vs ROSIGLITAZONE ROMOSOZUMAB-AQQG vs ROSUVASTATIN

Related Pages

ROMOSOZUMAB-AQQG Full Profile All Bone density abnormal Reports All Drugs Causing Bone density abnormal ROMOSOZUMAB-AQQG Demographics